Related references
Note: Only part of the references are listed.Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases
L. Righi et al.
ANNALS OF ONCOLOGY (2010)
Internalized Somatostatin Receptor Subtype 2 in Neuroendocrine Tumors of Octreotide-Treated Patients
Jean Claude Reubi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
Mario Duran-Prado et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines
M. Arvigo et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Regulation of prostate cancer cell proliferation by somatostatin receptor activation
Massimiliano Ruscica et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Pituitary tumours: The sst/D2 receptors as molecular targets
Leo J. Hofland et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Pasireotide and Octreotide Stimulate Distinct Patterns of sst2A Somatostatin Receptor Phosphorylation
Florian Poell et al.
MOLECULAR ENDOCRINOLOGY (2010)
Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways
Renzo Cescato et al.
MOLECULAR ENDOCRINOLOGY (2010)
Agonist-Induced Endocytosis and Receptor Phosphorylation Mediate Resensitization of Dopamine D2 Receptors
Dongim Cho et al.
MOLECULAR ENDOCRINOLOGY (2010)
Pituitary somatostatin receptor signaling
Anat Ben-Shlomo et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D2 Dopamine Receptor
Yoon Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
Christiaan de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
Anat Ben-Shlomo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
Mario Duran-Prado et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro
Sarah Lesche et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Differential regulation of human dopamine D-2 and somatostatin receptor subtype expression by glucocorticoids in vitro
C. de Bruin et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
Diego Ferone et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation
Rudolf Arnold et al.
NEUROENDOCRINOLOGY (2009)
Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies
R. Srirajaskanthan et al.
NEUROENDOCRINOLOGY (2009)
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome
C. de Bruin et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Somatostatin-dopamine ligands in the treatment of pituitary adenomas
Alexandru Saveanu et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
A G protein-coupled receptor at work: the rhodopsin model
Klaus Peter Hofmann et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
Mark Kidd et al.
CANCER (2008)
High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors
Erika Grossrubatscher et al.
CANCER BIOLOGY & THERAPY (2008)
Neuroendocrine tumors of the diffuse neuroendocrine system
Bjorn I. Gustafsson et al.
CURRENT OPINION IN ONCOLOGY (2008)
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
Tullio Florio et al.
ENDOCRINE-RELATED CANCER (2008)
Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
Hriday K. Das
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Correlation of in Vitro and in Vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy
Diego Ferone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells
Daniela Pasquali et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning
Mario Duran-Prado et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Selective agonism in somatostatin receptor signaling and regulation
Agnes Schonbrunn
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas
A. S. Aveanu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Pasireotide (SOM230): Development, mechanism of action and potential applications
Herbert A. Schmid
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Intracellular trafficking of somatostatin receptors
Stefan Jacobs et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
The role of somatostatin analogues in the treatment of neuroendocrine tumours
Simona Grozinsky-Glasberg et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Somatostatin, cortistatin and their receptors in tumours
M. Volante et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization
Michael Grant et al.
MOLECULAR ENDOCRINOLOGY (2008)
Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 - Co-immunoprecipitation and fluorescence resonance energy transfer analysis
Alessandra Baragli et al.
CELLULAR SIGNALLING (2007)
Somatostatin receptor scintigraphy in thoracic diseases
P. Ameri et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation
M. Kidd et al.
REGULATORY PEPTIDES (2007)
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin
Martijn van Essen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-β1 mediated regulatory abnormalities including up-regulation of c-Myc and MTA1
Mark Kidd et al.
CANCER (2007)
Novel insights in somatostatin receptor physiology
Giovanni Tulipano et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Novel chimeric somatostatin analogs: facts and perspectives
Diego Ferone et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas
Diego Ferone et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Novel insights in dopamine receptor physiology
Rosario Pivonello et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Dopamine receptor expression and function in corticotroph ectopic tumors
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Pulmonary carcinoid tumours: Indolent but not benign
Sara De Dosso et al.
ONCOLOGY (2007)
Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas
Giselle F. Taboada et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies
Dermot O'Toole et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
Dalia L. Batista et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: Potential clinical perspectives
Maria Chiara Zatelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Therapeutic options for gastrointestinal carcinoids
Irvin M. Modlin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas
SV de Sá et al.
ENDOCRINE-RELATED CANCER (2006)
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Vsevolod V. Gurevich et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas
Alexandru Saveanu et al.
NEUROENDOCRINOLOGY (2006)
Rare functioning pancreatic endocrine tumors
Dermot O'Toole et al.
NEUROENDOCRINOLOGY (2006)
Well-differentiated pancreatic nonfunctioning tumors/carcinoma
Massimo Falconi et al.
NEUROENDOCRINOLOGY (2006)
Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland
B Ueberberg et al.
HORMONE AND METABOLIC RESEARCH (2005)
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
D Ferone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro
C Zatelli et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients
J van der Hoek et al.
CLINICAL ENDOCRINOLOGY (2005)
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
P Jaquet et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Cabergoline plus lanreotide for ectopic Cushing's syndrome
R Pivonello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Case 3.: Plasmacytoma mimicking a paraganglioma of the skull base:: Diagnostic value of somatostatin receptor scintigraphy
M Duet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Hypothalamic hormones a.k.a. hypothalamic releasing factors
R Guillemin
JOURNAL OF ENDOCRINOLOGY (2005)
Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets
EGR Lichtenauer-Kaligis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor
RD Pathak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Agonist-dependent dissociation of human somatostatin receptor 2 dimers - A role in receptor trafficking
M Grant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor
Y Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumors
N Unger et al.
ENDOCRINE RESEARCH (2004)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Homo- and hetero-oligomerization of G protein-coupled receptors
SP Lee et al.
LIFE SCIENCES (2003)
Octreoscan in patients with bronchial carcinoid tumours
D Granberg et al.
CLINICAL ENDOCRINOLOGY (2003)
Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion
SG Ren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
The pathophysiological consequences of somatostatin receptor internalization and resistance
LJ Hofland et al.
ENDOCRINE REVIEWS (2003)
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
G Weckbecker et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Somatostatin receptor subtypes in human pheochromocytoma: Subcellular expression pattern and functional relevance for octreotide scintigraphy
J Mundschenk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand
SG Ren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes
D Ferone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Homologous and heterologous regulation of somatostatin receptor 2
G Elberg et al.
MOLECULAR ENDOCRINOLOGY (2002)
Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes
RC Patel et al.
METHODS (2002)
Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells
K Lemmer et al.
LIFE SCIENCES (2002)
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors -: A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
M Papotti et al.
VIRCHOWS ARCHIV (2002)
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies
H Kulaksiz et al.
GUT (2002)
Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment
K Oberg
CURRENT OPINION IN ONCOLOGY (2002)
Dopamine as a prolactin (PRL) inhibitor
N Ben-Jonathan et al.
ENDOCRINE REVIEWS (2001)
Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours -: Correlation with preoperative octreotide scintigraphy
M Papotti et al.
VIRCHOWS ARCHIV (2001)
Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma
KD Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features
D Ferone et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis
RH Oakley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
M Papotti et al.
CLINICAL ENDOCRINOLOGY (2001)
Homo- and heterodimerization of somatostatin receptor subtypes -: Inactivation of sst3 receptor function by heterodimerization with sst2A
M Pfeiffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Dopamine D2 receptor gene expression in human adenohypophysial adenomas
L Stefaneanu et al.
ENDOCRINE (2001)
Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease:: more extended disease identified
PJ Lugtenburg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
BIM-23244, a somatastatin receptor subtype 2-and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas
A Saveanu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems:: Membranous versus intracellular location
JC Reubi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors
S Ricci et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors
RH Oakley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Type-specific sorting of G protein-coupled receptors after endocytosis
PI Tsao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
M Rocheville et al.
SCIENCE (2000)
Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
M Rocheville et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung
P Papotti et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2000)
Share Paper
